Finanzwire Finanzwire
Basculer en Français
9778 Companies
195714 Keywords
126751 Articles
104068 Press releases
Headlines Articles Press releases ONXEO Remove
  1. Home
  2. Companies
  3. ONXEO
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/22/2024 at 20:51, 1 year 8 months ago

    Valerio Therapeutics Advances VIO-01 Clinical Trial with Positive Results

    Drug Development Solid Tumors Clinical Trial Valerio Therapeutics VIO-01
  • PRESS RELEASE

    published on 05/22/2024 at 20:46, 1 year 8 months ago

    Inside Information / Other news releases

    Valerio Therapeutics completes dosing for first cohort of subjects in Phase 1/2 VIO-01 trial for solid tumors, showing encouraging tolerability. Phase 1b aims to determine recommended dose in selected solid tumors
    Solid Tumors Valerio Therapeutics VIO-01 Trial Phase 1/2 DNA Damage Response
    Logo of ONXEO
  • BRIEF

    published on 04/30/2024 at 23:19, 1 year 9 months ago

    Valerio Therapeutics Reports 2023 Fiscal Year Results and Clinical Updates

    Biotechnology Clinical Trials Financial Results 2023 Valerio Therapeutics VIO-01
  • PRESS RELEASE

    published on 04/30/2024 at 23:14, 1 year 9 months ago

    Annual financial and audit reports / Terms of availability of the annual financial report

    Valerio Therapeutics reports full year 2023 financial results and provides clinical development updates. The company's cash position is €6.8 million as of December 31, 2023, ensuring financial visibility until Q4 2024
    Financial Results Cash Position 2023 Clinical Development Valerio Therapeutics
    Logo of ONXEO
Previous page
1 2 3
Accesswire
  • Published on 02/02/2026 at 00:05, 6 hours 26 minutes ago

    Resource Upgrade Drilling Begins on Challenger Open Pits

  • Published on 01/31/2026 at 03:15, 2 days 3 hours ago

    Empress Royalty Announces Grant Of Restricted Share Units

  • Published on 01/31/2026 at 02:20, 2 days 4 hours ago

    Boron One Announces First Closing of Financing

  • Published on 01/31/2026 at 01:40, 2 days 4 hours ago

    Star Copper Announces Grant of RSUs, Stock Options and PSUs

  • Published on 01/31/2026 at 00:00, 2 days 6 hours ago

    BE Resources Announces Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 02/02/2026 at 02:50, 3 hours 41 minutes ago

    Xinhua Silk Road: Ecosystem and sustainability redefine global automotive brand value: report

  • Published on 02/01/2026 at 20:25, 10 hours 6 minutes ago

    WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China

  • Published on 01/31/2026 at 15:54, 1 day 14 hours ago

    EQS-Adhoc: Wolford AG: Capital increase will not be implemented

  • Published on 01/31/2026 at 12:25, 1 day 18 hours ago

    JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL

  • Published on 01/31/2026 at 02:45, 2 days 3 hours ago

    CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK

View all EQS
Les Echos
  • Published on 01/30/2026 at 17:45, 2 days 12 hours ago

    Schneider Electric launches a capital increase reserved for employees

  • Published on 01/30/2026 at 08:00, 2 days 22 hours ago

    AMA: 4th Quarter & FY 2025 Revenues

  • Published on 01/29/2026 at 18:00, 3 days 12 hours ago

    GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%

  • Published on 01/29/2026 at 17:45, 3 days 12 hours ago

    LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE

  • Published on 01/29/2026 at 17:45, 3 days 12 hours ago

    Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy